Arvinas (ARVN) Net Cash Flow (QoQ) (2018 - 2026)
Arvinas (ARVN) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -234.30% |
| Dec 31, 2025 | 408.96% |
| Sep 30, 2025 | -139.53% |
| Jun 30, 2025 | 273.85% |
| Mar 31, 2025 | -227.45% |
| Dec 31, 2024 | 120.37% |
| Sep 30, 2024 | -212.43% |
| Jun 30, 2024 | 129.86% |
| Mar 31, 2024 | -212.98% |
| Dec 31, 2023 | 757.14% |
| Sep 30, 2023 | 158.33% |
| Jun 30, 2023 | -180.98% |
| Mar 31, 2023 | 195.32% |
| Dec 31, 2022 | -226.98% |
| Sep 30, 2022 | 30.74% |
| Jun 30, 2022 | 167.17% |
| Mar 31, 2022 | 68.79% |
| Dec 31, 2021 | -171.21% |
| Sep 30, 2021 | 170.67% |
| Jun 30, 2021 | -20.88% |